Peter Lindblom

Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.

K. Fan, R. Gregg, Zhijie Liu, 2016, Journal of medicinal chemistry.

An electronic environment and contact direction sensitive scoring function for predicting affinities of protein-ligand complexes in Contour(®).

Kam-Chuen Jim, R. Gregg, Zhijie Liu, 2014, Journal of molecular graphics & modelling.

Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase type 1.

Suresh B. Singh, P. Carroll, D. Claremon, 2011, Journal of medicinal chemistry.

Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11β hydroxysteroid dehydrogenase type 1 inhibitor.

Suresh B. Singh, B. Hamilton, D. Lala, 2017, Bioorganic & medicinal chemistry.

Chapter 11:Structure-based Design Technology CONTOUR and its Application to Drug Discovery

Zhijie Liu, Suresh B. Singh, Peter Lindblom, 2012 .

Discovery of Potent Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 Using a Novel Growth-Based Protocol of in Silico Screening and Optimization in CONTOUR

Yi Zhao, Robert Cain, Yajun Zheng, 2019, J. Chem. Inf. Model..

Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1.

R. Gregg, Suresh B. Singh, H. Nar, 2010, Bioorganic & medicinal chemistry letters.

Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design.

Suresh B. Singh, D. Claremon, C. Tice, 2010, Bioorganic & medicinal chemistry letters.